Our story

2B-BLUE builds on the work initiated by the Interreg MED project B-Blue project which ran from September 1, 2020 to September 30, 2022.

B-Blue established a preliminary network of actors working in blue biotechnology and analyzed best practices, key drivers, barriers and readiness factors affecting the adoption of blue biotechnologies by Euro-Med companies. This work helped identify the most promising blue biotechnology value chains for the Euro-Med area.

The project also established five interactive Blue Biotechnology Hubs (BBHs) to facilitate collaboration, knowledge transfer and innovation across marine biotechnology value chains while addressing the challenges identified. In parallel, a digital community was developed through the B-Blue MatchMaking Tool to support new joint initiatives. B-Blue also contributed to the launch of the Mediterranean Innovation Alliance for Sustainable BlueBioeconomy (MedIA) in collaboration with Blue Bio Med, including two dedicated working groups on blue biotechnology.

2B-BLUE builds on these achievements and aims to capitalize on the positive results of B-Blue. In particular, the challenges identified by B-Blue, especially those related to financing, standardization and public-private cooperation, can be transformed into opportunities for further development.

Through this approach, 2B-BLUE seeks to support more sustainable and efficient processes while contributing to a better-structured blue biotechnology sector across the Mediterranean.

2B-BLUE is structured into two phases: Test (January 2024 to June 2026) and Transfer (July 2026 to March 2028). During the first phase, the project reached a high level of technical, organisational and strategic maturity. Its core outputs were developed, consolidated and largely finalised, while the solutions were extensively tested under real-life conditions across the Mediterranean area. The second phase focused on the transfer, replication and upscaling of the validated solutions developed and tested at the demonstration sites.

 

 

Who we are